Literature DB >> 20592141

Performance of the Aptima HIV-1 RNA qualitative assay with 16- and 32-member specimen pools.

Steven F Ethridge1, Clyde Hart, Debra L Hanson, Monica M Parker, Timothy J Sullivan, Berry Bennett, Petrice Stephens, Joslyn Hilliard, Pragna Patel.   

Abstract

The Aptima HIV-1 RNA qualitative assay tested with a WHO-approved HIV type 1 RNA standard in 16- and 32-member pools detected 100% of the pools (1,070 and 2,130 HIV-1 RNA copies/ml/pool, respectively), thus exceeding the FDA-required lower limit of detection. The Aptima test can be used to screen for acute-phase HIV infection.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20592141      PMCID： PMC2937729          DOI： 10.1128/JCM.01030-10

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  6 in total

1.  Sensitivity of HCV RNA and HIV RNA blood screening assays.

Authors:  P Nico Lelie; Harry A J van Drimmelen; H Theo M Cuypers; Susan J Best; Susan L Stramer; Catherine Hyland; Jean-Pierre Allain; Pierre Moncharmont; Christine Defer; Micha Nübling; Andreas Glauser; Marcia da Silva Cardoso; Jean-François Viret; Mervi H Lankinen; Lena Grillner; Urs Wirthmüller; Joliette Coste; Volkmar Schottstedt; Barbara Masecar; Elizabeth M Dax
Journal:  Transfusion       Date:  2002-05       Impact factor: 3.157

2.  Detection of acute infections during HIV testing in North Carolina.

Authors:  Christopher D Pilcher; Susan A Fiscus; Trang Q Nguyen; Evelyn Foust; Leslie Wolf; Del Williams; Rhonda Ashby; Judy Owen O'Dowd; J Todd McPherson; Brandt Stalzer; Lisa Hightow; William C Miller; Joseph J Eron; Myron S Cohen; Peter A Leone
Journal:  N Engl J Med       Date:  2005-05-05       Impact factor: 91.245

3.  Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing.

Authors:  Susan L Stramer; Simone A Glynn; Steven H Kleinman; D Michael Strong; Sally Caglioti; David J Wright; Roger Y Dodd; Michael P Busch
Journal:  N Engl J Med       Date:  2004-08-19       Impact factor: 91.245

4.  Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection.

Authors:  Eberhard W Fiebig; David J Wright; Bhupat D Rawal; Patricia E Garrett; Richard T Schumacher; Lorraine Peddada; Charles Heldebrant; Richard Smith; Andrew Conrad; Steven H Kleinman; Michael P Busch
Journal:  AIDS       Date:  2003-09-05       Impact factor: 4.177

5.  Detecting acute human immunodeficiency virus infection using 3 different screening immunoassays and nucleic acid amplification testing for human immunodeficiency virus RNA, 2006-2008.

Authors:  Pragna Patel; Duncan Mackellar; Pat Simmons; Apurva Uniyal; Kathleen Gallagher; Berry Bennett; Timothy J Sullivan; Alexis Kowalski; Monica M Parker; Marlene LaLota; Peter Kerndt; Patrick S Sullivan
Journal:  Arch Intern Med       Date:  2010-01-11

6.  Alternative algorithms for human immunodeficiency virus infection diagnosis using tests that are licensed in the United States.

Authors:  S M Owen; C Yang; T Spira; C Y Ou; C P Pau; B S Parekh; D Candal; D Kuehl; M S Kennedy; D Rudolph; W Luo; N Delatorre; S Masciotra; M L Kalish; F Cowart; T Barnett; R Lal; J S McDougal
Journal:  J Clin Microbiol       Date:  2008-03-05       Impact factor: 5.948
  6 in total
  4 in total

1.  Evaluation of pooling strategies for acute HIV-1 infection screening using nucleic acid amplification testing.

Authors:  Timothy J Sullivan; Pragna Patel; Angela Hutchinson; Steven F Ethridge; Monica M Parker
Journal:  J Clin Microbiol       Date:  2011-08-10       Impact factor: 5.948

2.  Evaluation of the Gen-Probe Aptima HIV-1 RNA qualitative assay as an alternative to Western blot analysis for confirmation of HIV infection.

Authors:  Virginia M Pierce; Brandy Neide; Richard L Hodinka
Journal:  J Clin Microbiol       Date:  2011-02-23       Impact factor: 5.948

Review 3.  Molecular methods and platforms for infectious diseases testing a review of FDA-approved and cleared assays.

Authors:  Rajyasree Emmadi; Jerry B Boonyaratanakornkit; Rangaraj Selvarangan; Venkatakrishna Shyamala; Barbara L Zimmer; Laurina Williams; Bonita Bryant; Ted Schutzbank; Michele M Schoonmaker; Jean A Amos Wilson; Leslie Hall; Preeti Pancholi; Kathryn Bernard
Journal:  J Mol Diagn       Date:  2011-08-25       Impact factor: 5.568

Review 4.  Limitations and opportunities of technologies for the analysis of cell-free DNA in cancer diagnostics.

Authors:  Ping Song; Lucia Ruojia Wu; Yan Helen Yan; Jinny X Zhang; Tianqing Chu; Lawrence N Kwong; Abhijit A Patel; David Yu Zhang
Journal:  Nat Biomed Eng       Date:  2022-01-31       Impact factor: 29.234
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.